Supine or sitting plasma metanephrine screening? A unifying solution for patients and doctors

Affiliations

Comment

Vasileios Chortis et al. Clin Endocrinol (Oxf). 2015 May.

. 2015 May;82(5):776-7.

doi: 10.1111/cen.12659. Epub 2014 Dec 22.

¹ School of Clinical and Experimental Medicine, University of Birmingham, Birmingham, UK. v.chortis@bham.ac.uk.

No abstract available

Comment on

Supine or sitting? Economic considerations regarding patient position during plasma metanephrine analysis for the exclusion of chromaffin tumours.
Chortis V, Bancos I, Crowley RK, Arlt W. Chortis V, et al. Clin Endocrinol (Oxf). 2015 Mar;82(3):462-3. doi: 10.1111/cen.12587. Epub 2014 Sep 25. Clin Endocrinol (Oxf). 2015. PMID: 25130622 No abstract available.
Supine or sitting? the voice of the patient stakeholders: economics vs clinically and medically sound.
Sussman I, Rothwell T, Wilson A. Sussman I, et al. Clin Endocrinol (Oxf). 2015 Mar;82(3):464-5. doi: 10.1111/cen.12624. Epub 2014 Oct 29. Clin Endocrinol (Oxf). 2015. PMID: 25265273 No abstract available.